$MDBH
MDB Capital Holdings LLC Stock $mdbh

$mdbh Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224031651 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$723.5K	$237.4K
YoY Change	2489.8%	3037.23%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$8.105M	$7.413M
YoY Change	221.18%	236.9%
Operating Profit	-$8.720M	-$5.125M
YoY Change	1024.53%	-189.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.440M	-$4.804M
YoY Change	170.29%	-229.35%
Income Tax		$2.143K
% Of Pretax Income
Net Earnings	-$7.735M	-$4.274M
YoY Change	142.77%	-225.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	4.296M shares	4.296M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$16.68M	$17.52M
Short-Term Investments
Other Short-Term Assets	$30.10K	$71.50K
YoY Change	-94.64%	-69.3%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$835.8K	$910.3K
YoY Change	-0.78%	56.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.898M	$3.060M
YoY Change	-83.7%	46.6%
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets	$2.898M	$3.060M
Total Assets	$34.21M	$37.71M
YoY Change	-21.29%	37.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue	$51.30K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$6.029M	$5.150M
YoY Change	45.55%	86.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.32M	-$23.58M
YoY Change	400.66%	567.12%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.00M	$32.98M
YoY Change
Total Liabilities & Shareholders Equity	$34.21M	$37.71M
YoY Change	-21.29%	37.53%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$7.735M	-$4.274M
YoY Change	142.77%	-225.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	767707	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514976	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	MDBH	Purchases From Sale Of Investment Securities PurchasesFromSaleOfInvestmentSecurities		usd
	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers		usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	MDBH	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability		usd
	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering		usd
CY2024Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain		usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q2	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2024Q2	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased		usd
CY2024Q2	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56565645	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49405779	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23582793	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12092927	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	32982852	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37312852	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-426991	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7250	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32555861	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37705537	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42985279	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	899544	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	152276	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	1303398	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	4233120	usd
	us-gaap	Fee Income FeeIncome	1303398	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
CY2024Q2	us-gaap	Other Operating Income OtherOperatingIncome	85508	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	67159	usd
	us-gaap	Other Operating Income OtherOperatingIncome	172387	usd
CY2024Q2	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	2288450	usd
CY2023Q2	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	5729371	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	1628061	usd
CY2024Q2	MDBH	Compensation Costs CompensationCosts	5124758	usd
CY2023Q2	MDBH	Compensation Costs CompensationCosts	973717	usd
	MDBH	Compensation Costs CompensationCosts	10017433	usd
CY2024Q2	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	304954	usd
CY2023Q2	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	253951	usd
	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	625246	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	640620	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	176842	usd
	us-gaap	Professional Fees ProfessionalFees	1559709	usd
CY2024Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	209396	usd
CY2023Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	168142	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	415387	usd
CY2024Q2	MDBH	Clearing And Other Charges ClearingAndOtherCharges	226426	usd
CY2023Q2	MDBH	Clearing And Other Charges ClearingAndOtherCharges	368924	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	228462	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	669631	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	251258	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1338757	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7175785	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2192834	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14184994	usd
CY2024Q2	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	609208	usd
	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	1317878	usd
	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	1522087	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	237394	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7567	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7413179	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2200401	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14699970	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5124729	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3528970	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13071909	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	321008	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	184888	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	658860	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4803721	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3713858	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12413049	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4805864	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
	us-gaap	Profit Loss ProfitLoss	-12415192	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-531423	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-69585	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-925326	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4274441	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3462859	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11489866	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3812808	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33523582	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3838143	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4805864	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32555861	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54126	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21195193	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58951	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
	us-gaap	Profit Loss ProfitLoss	-12415192	usd
	us-gaap	Profit Loss ProfitLoss	1425333	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	152276	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7650951	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	113077	usd
	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	446701	usd
	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	322341	usd
	MDBH	Purchases From Sale Of Investment Securities PurchasesFromSaleOfInvestmentSecurities	1587500	usd
	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	632851	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	225874	usd
	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal	165087	usd
	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	359605	usd
	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	2645620	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130937	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88249	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	38781	usd
	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	-26252	usd
	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	25920	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-20000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	170581	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	166957	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-153329	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-97334	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	264852	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	264492	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-34874	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-79418	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	255222	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	75477	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-19966	usd
	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers	-418881	usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	977020	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-957644	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-148664	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6468895	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3647022	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	35825998	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5107908	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	15762378	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3499352	usd
	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	6180	usd
	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	-74295	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	174734	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43691	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19895066	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1490570	usd
	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	282175	usd
	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	405029	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-282175	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-405029	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13143996	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2561481	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20501683	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2391143	usd
	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	359605	usd
	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	2480533	usd
	MDBH	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability	198544	usd
	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering	152065	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17523769	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2024Q2	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	2977914	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1247881	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20501683	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z9HUKziHgNMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zuqE7K7cFlZh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the disclosure of contingent assets and liabilities. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in the valuation of investment securities, valuing equity instruments issued for services, stock-based compensation and the realization of any deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	MDBH	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2024Q2	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	2977914	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2024Q2	MDBH	Clearing Deposits Current ClearingDepositsCurrent	515222	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	488914	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	60000	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	47380	usd
	MDBH	Prepaid Lab Equipment PrepaidLabEquipment	67000	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	199534	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	71500	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2023	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	95000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	47380	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	325777	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	12131	usd
CY2024Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5041692	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	6285443	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2024Q2	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	899544	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	152276	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
CY2024Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5041692	usd
CY2024Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	24689	usd
CY2024Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	5017003	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	6031	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	24664642	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	6285443	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	315885	usd
	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-271691	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3177652	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3177652	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	2645620	usd
CY2023	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	652925	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	165087	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1502543	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1327809	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	592256	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461319	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	910287	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	80000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20000	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1272127	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1467202	usd
	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased	6379	usd
	MDBH	Grant Fees GrantFees	39372	usd
	MDBH	Grant Fees GrantFees	54886	usd
	MDBH	Grant Funds Received GrantFundsReceived	-1053026	usd
	MDBH	Grant Funds Received GrantFundsReceived	-1257596	usd
CY2024Q2	us-gaap	Grants Receivable GrantsReceivable	1147171	usd
CY2023Q2	us-gaap	Grants Receivable GrantsReceivable	1074024	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1272127	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1467202	usd
	MDBH	Grant Drawdowns GrantDrawdowns	1317878	usd
	MDBH	Grant Drawdowns GrantDrawdowns	1522088	usd
CY2024Q2	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	846602	usd
CY2023Q2	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	775274	usd
	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	1832855	usd
	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	1561247	usd
CY2024Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	62537	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	21178	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	104760	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	55598	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3059825	usd
CY2024Q2	us-gaap	Assets Assets	37705537	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	899544	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	1303398	usd
CY2024Q2	us-gaap	Other Operating Income OtherOperatingIncome	85508	usd
CY2024Q2	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	2288450	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5124758	usd
CY2024Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	304954	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	640620	usd
CY2024Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	209396	usd
CY2024Q2	MDBH	Clearing And Other Charges ClearingAndOtherCharges	226426	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	669631	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7175785	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	237394	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	7413179	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5124729	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	321008	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4803721	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4805864	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-531423	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4274441	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	152276	usd
	us-gaap	Fee Income FeeIncome	1303398	usd
	us-gaap	Other Operating Income OtherOperatingIncome	172387	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	1628061	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10017433	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	625246	usd
	us-gaap	Professional Fees ProfessionalFees	1559709	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	415387	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	228462	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1338757	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14184994	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514976	usd
	us-gaap	Operating Expenses OperatingExpenses	14699970	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13071909	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	658860	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12413049	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
	us-gaap	Profit Loss ProfitLoss	-12415192	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-925326	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11489866	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3186609	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	4233120	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	67159	usd
CY2023Q2	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	5729371	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	973717	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	253951	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	176842	usd
CY2023Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	168142	usd
CY2023Q2	MDBH	Clearing And Other Charges ClearingAndOtherCharges	368924	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	251258	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2192834	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7567	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2200401	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3528970	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	184888	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3713858	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-69585	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3462859	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
	us-gaap	Other Operating Income OtherOperatingIncome	129371	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	5846362	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1845744	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	555653	usd
	us-gaap	Professional Fees ProfessionalFees	781504	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	315549	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	379678	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	555337	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4433465	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39159	usd
	us-gaap	Operating Expenses OperatingExpenses	4472624	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1373738	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	372179	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1745917	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
	us-gaap	Profit Loss ProfitLoss	1425333	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-163778	usd
	us-gaap	Net Income Loss NetIncomeLoss	1589111	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1018012	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.66
	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2085368	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.43
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M19D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1451737	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.50
	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6752	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3636	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3526717	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y11M1D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	519350	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M14D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	756886	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y11M1D
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	625246	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	555653	usd
CY2024Q2	srt	Net Capital NetCapital	5762368	usd
CY2023Q2	srt	Net Capital NetCapital	2862041	usd
CY2024Q2	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	5606016	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	0.93 to 1
CY2024Q2	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	0.02	pure
CY2024Q2	srt	Minimum Net Capital Required For Entity1 MinimumNetCapitalRequiredForEntity1	0	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	348121	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	294943	usd
	MDBH	Payment For Licensed Products PaymentForLicensedProducts	250000	usd
	MDBH	Cumulative Net Sales CumulativeNetSales	1000000	usd
CY2023Q2	us-gaap	Advance Rent AdvanceRent	14371	usd
CY2023Q2	MDBH	Base Rent BaseRent	16747	usd
CY2023Q2	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.025	pure
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P60M
CY2023Q4	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend for 60 additional months
CY2023Q4	us-gaap	Advance Rent AdvanceRent	13277	usd
CY2023Q4	MDBH	Base Rent BaseRent	15391	usd
CY2023Q4	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.030	pure
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P91M
CY2022Q3	us-gaap	Advance Rent AdvanceRent	12556	usd
CY2022Q3	MDBH	Base Rent BaseRent	13937	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2149538	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2262560	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M29D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0740	pure
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	243375	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	206837	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1018002	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	90047	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	146836	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	170582	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	275589	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	260629	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	422425	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	248249	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	503684	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	516001	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	528586	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	541674	usd
CY2024Q2	MDBH	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	451600	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2789794	usd
CY2024Q2	MDBH	Less Effects Of Discounting LessEffectsOfDiscounting	-527234	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2262560	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2024Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	150000	usd
CY2024Q2	us-gaap	Investments Investments	5000000	usd

Files In Submission

Name	View Source	Status
0001493152-24-031651-index-headers.html	Edgar Link	pending
0001493152-24-031651-index.html	Edgar Link	pending
0001493152-24-031651.txt	Edgar Link	pending
0001493152-24-031651-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
mdbh-20240630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
mdbh-20240630_cal.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
mdbh-20240630_def.xml	Edgar Link	unprocessable
mdbh-20240630_pre.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mdbh-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDBH
MDB Capital Holdings LLC Stock $mdbh

2024 Q3 Form 10-Q Financial Statement

#000149315224031651 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH MDB Capital Holdings LLC Stock $mdbh

2024 Q3 Form 10-Q Financial Statement

#000149315224031651 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH
MDB Capital Holdings LLC Stock $mdbh